Partners HealthCare System Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Partners HealthCare System Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013383
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Partners HealthCare System Inc (PHS) is a nonprofit integrated health care organization. It operates a network of community and specialty hospitals, a physician network, managed care organizations, home health and long-term care centers, community health centers and other health care entities. The organization focuses on providing patient care, research, teaching, and other services to patients and their families in the community through its network. It offers a wide range of services primarily to patients from the Greater Boston area along with New England and beyond. PHS holds expertise in the area of biomedical research, and is a principal teaching affiliate of Harvard Medical School. The organization is formed by the joint effort of Brigham and Women’s Hospital and Massachusetts General Hospital. PHS is headquartered at Boston, Massachusetts, the US.

Partners HealthCare System Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Partners HealthCare System Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Partners HealthCare System Inc, Medical Devices Deals, 2011 to YTD 2017 9
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Partners HealthCare Receives Approval from State Attorney General to Acquire South Shore Hospital 14
Partners HealthCare To Acquire Two Hospitals From Hallmark Health 15
Venture Financing 16
Magenta Therapeutics Raises USD50 Million in Series B Financing 16
Syntimmune Raises USD8 Million in Final Tranche of Series A Financing Round 18
ImmuneXcite Raises USD8.6 Million in Series A-1 Financing 19
Syntimmune Raises USD10 Million in Second Tranche of Series A Financing Round 20
Spero Therapeutics to Raise USD30 Million in Series B Preferred Financing 21
Editas Medicine Raises USD120 Million in Series B Financing 22
Spero Therapeutics Raises USD30 Million in Extended Series A Financing 24
Lysosomal Therapeutics Raises USD20 Million in Series A Financing 25
Quartet Medicine Raises USD17 Million in Series A Venture Financing 26
Raze Therapeutics Raises USD24 Million in Series A Venture Financing 27
Lysosomal Therapeutics Raises US$4.8 Million In Seed Financing 29
Spero Therapeutics Raises USD3 Million in Series A Venture Financing 31
Editas Medicine Raises US$43 Million In Series A Financing 32
Annovation BioPharma Raises US$8 Million In Series A Financing 34
RaNA Therapeutics Raises Additional US$18 Million In Series A Financing 35
Partnerships 37
Jiahui International Hospital, Partners HealthCare International and Brigham and Women’s Hospital to Co-Develop Women’s Health Center 37
Partners HealthCare to Form Joint Venture with MedSpring Urgent Care 38
Acquisition 39
Novartis Acquires CoStim Pharma 39
Partners HealthCare Completes Acquisition Of Cooley Dickinson Hospital 41
Partners HealthCare System Inc – Key Competitors 42
Partners HealthCare System Inc – Key Employees 43
Partners HealthCare System Inc – Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Joint Venture 44
Recent Developments 45
Government and Public Interest 45
Oct 13, 2016: NIH funds additional medical centers to expand national precision medicine research program 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Partners HealthCare System Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Partners HealthCare System Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Partners HealthCare System Inc, Medical Devices Deals, 2011 to YTD 2017 9
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Partners HealthCare Receives Approval from State Attorney General to Acquire South Shore Hospital 14
Partners HealthCare To Acquire Two Hospitals From Hallmark Health 15
Magenta Therapeutics Raises USD50 Million in Series B Financing 16
Syntimmune Raises USD8 Million in Final Tranche of Series A Financing Round 18
ImmuneXcite Raises USD8.6 Million in Series A-1 Financing 19
Syntimmune Raises USD10 Million in Second Tranche of Series A Financing Round 20
Spero Therapeutics to Raise USD30 Million in Series B Preferred Financing 21
Editas Medicine Raises USD120 Million in Series B Financing 22
Spero Therapeutics Raises USD30 Million in Extended Series A Financing 24
Lysosomal Therapeutics Raises USD20 Million in Series A Financing 25
Quartet Medicine Raises USD17 Million in Series A Venture Financing 26
Raze Therapeutics Raises USD24 Million in Series A Venture Financing 27
Lysosomal Therapeutics Raises US$4.8 Million In Seed Financing 29
Spero Therapeutics Raises USD3 Million in Series A Venture Financing 31
Editas Medicine Raises US$43 Million In Series A Financing 32
Annovation BioPharma Raises US$8 Million In Series A Financing 34
RaNA Therapeutics Raises Additional US$18 Million In Series A Financing 35
Jiahui International Hospital, Partners HealthCare International and Brigham and Women's Hospital to Co-Develop Women's Health Center 37
Partners HealthCare to Form Joint Venture with MedSpring Urgent Care 38
Novartis Acquires CoStim Pharma 39
Partners HealthCare Completes Acquisition Of Cooley Dickinson Hospital 41
Partners HealthCare System Inc, Key Competitors 42
Partners HealthCare System Inc, Key Employees 43
Partners HealthCare System Inc, Subsidiaries 44
Partners HealthCare System Inc, Joint Venture 44

★海外企業調査レポート[Partners HealthCare System Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sky Metals Ltd (SKY):企業の財務・戦略的SWOT分析
    Summary Sky Metals Ltd (Sky Metals) is an upstream oil and gas company that offers acquisition, exploration, production and development of oil and gas properties in the US. The company holds interests in conventional and unconventional oil and gas projects in Australia. It projects explores for coal …
  • Macquarie Infrastructure Corporation:企業のM&A・事業提携・投資動向
    Macquarie Infrastructure Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Macquarie Infrastructure Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Cabot Corp (CBT):企業の財務・戦略的SWOT分析
    Cabot Corp (CBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • LGC Ltd:医療機器:M&Aディール及び事業提携情報
    Summary LGC Ltd (LGC), formerly LGC (Teddington) Ltd is a life sciences measurement and testing company that offers reference materials, genomics solutions and analytical testing products and services. The company’s products comprise DNA extraction instrumentation, DNA extraction kits, Douglas scien …
  • Mendor Oy-製薬・医療分野:企業M&A・提携分析
    Summary Mendor Oy (Mendor) is a medical equipment company that designs, develops and markets advanced diabetes management products. The company’s products include portable blood glucose meter and web-based software application for the daily management of diabetes. It offers blood glucose meter mendo …
  • Exide Technologies:企業の戦略・SWOT・財務分析
    Exide Technologies - Strategy, SWOT and Corporate Finance Report Summary Exide Technologies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nakanishi Inc (7716):企業の財務・戦略的SWOT分析
    Nakanishi Inc (7716) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • China Health Group Inc (8225):企業の財務・戦略的SWOT分析
    China Health Group Inc (8225) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Public Financial Holdings Limited (626):企業の財務・戦略的SWOT分析
    Public Financial Holdings Limited (626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Tieto Corporation:企業のM&A・事業提携・投資動向
    Tieto Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tieto Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Glavbolgarstroy Holdings AD:企業の戦略・SWOT・財務情報
    Glavbolgarstroy Holdings AD - Strategy, SWOT and Corporate Finance Report Summary Glavbolgarstroy Holdings AD - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Dana Petroleum Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Dana Petroleum Ltd (Dana), a wholly-owned subsidiary of Korea National Oil Corp (KNOC), is an upstream oil and gas company. It explores, develops and produces oil and gas from its assets in the Europe and the Middle East. The company has interests and operations in the UK, the Netherlands, D …
  • Direct Energy Marketing Ltd:企業の戦略的SWOT分析
    Direct Energy Marketing Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Vericel Corp (VCEL)-医療機器分野:企業M&A・提携分析
    Summary Vericel Corp (Vericel) formerly Aastrom Biosciences, Inc. is a medical device company that develops patient-specific expanded cellular therapies to repair and regenerate damaged tissue for the treatment of severe, chronic ischemic cardiovascular diseases. It markets two autologous cell thera …
  • Invuity Inc (IVTY):企業の財務・戦略的SWOT分析
    Summary Invuity Inc (Invuity) is a medical technology company that develops and markets advanced surgical devices for the minimally invasive and minimal access procedures. The company offers illuminated surgical retractors, single-use handheld aspiration and universal drop-in intracavity illuminator …
  • Helomics Corp-製薬・医療分野:企業M&A・提携分析
    Summary Helomics Corp(Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company’s products include chemofx, biospecifx, genefx colon and genefx lung. Its chemofx is a drug response marker, which is used to test tumor …
  • Nippon Suisan Kaisha, Ltd.:企業の戦略・SWOT・財務分析
    Nippon Suisan Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Suisan Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • China State Construction International Holdings Limited:戦略・SWOT・企業財務分析
    China State Construction International Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary China State Construction International Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • LyondellBasell Industries NV (LYB):石油・ガス:M&Aディール及び事業提携情報
    Summary LyondellBasell Industries NV (LyondellBasell) is a chemical company. It produces and sells petrochemicals, plastics and basic chemicals. The company also refines crude oil to convert into refined products such as gasoline, diesel and jet fuel. Its major chemical products include polyolefins …
  • Applied Materials Inc (AMAT):企業の財務・戦略的SWOT分析
    Applied Materials Inc (AMAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆